KBH heads into its Q2 earnings report today with an unusual tension at its core: a 19% price rally over the past month running headlong into short interest that remains near its highest level of the year.
Short sellers have not backed down despite the rally. Short interest holds at 11.3% of the free float — a genuinely elevated reading for a homebuilder — and has actually grown about 12% over the past month in share terms, even as it edged slightly lower on the week. With days to cover at 7.35, it would take roughly a week and a half for shorts to unwind if they needed to exit in a hurry. Borrow conditions remain relaxed: availability is running near 400% of outstanding short interest, meaning there are roughly four shares available to lend for every one already borrowed. Cost to borrow is a negligible 0.53%. The lending market offers no squeeze pressure at current levels, but that could change quickly if the print forces a rethink.
Options positioning, by contrast, has turned more constructive. The put/call ratio has drifted down to 0.71, just below its 20-day average — meaning options traders are carrying modestly less downside protection than usual heading into the number. That lean is consistent with the price action: KBH has climbed alongside its homebuilder peers, with MTH, , and all gaining 2–3% on the week. is the outlier, down 3% over the same period, suggesting some sector-level divergence around Lennar's own recent results.
The analyst community has been cautious for months. Following the prior earnings release in late March, a broad swathe of firms — including Goldman Sachs, UBS, Barclays, and BofA — trimmed targets while holding ratings. That wave of cuts reflected the same concerns the bear case still rests on: order declines, a projected double-digit revenue drop for FY25, and EPS estimates that remain well below prior consensus. Truist cut its target again as recently as May 4, bringing it to $50. Bulls point to KB Home's return to a build-to-order model, which carries structurally higher gross margins than spec inventory, and to the possibility that order momentum has stabilised faster than feared. The mean analyst target sits near $55, fractionally above the current $53.84, suggesting the Street sees the stock as roughly fairly valued after the recent run.
Historical reactions to KBH prints have been consistently negative: the last three quarterly results each produced a one-day decline, ranging from roughly half a percent to just over 2%, with further softness extending into the following week. Today's print will test whether the 19% monthly re-rating has priced in a recovery in order volumes — or whether elevated short interest reflects a well-founded conviction that the numbers won't yet justify it.
See the live data behind this article on ORTEX.
Open KBH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
